Research Driven Investing strives to provide investors with free daily equity research reports analyzing major market events. Take a few minutes to register with us free at http://www.rdinvesting.com/ and get exclusive access to our numerous stock reports and market updates.

Black Diamond Inc. (NASDAQ: BDE) shares increased 4.62 percent to close at $10.88 a share Tuesday. The stock traded between $10.60 and $10.93 on volume of 468,632 shares traded. Analysts at Stifel have recently initiated coverage on the company with a "buy" rating. Shares of Black Diamond have gained approximately 32.0 percent year-to-date.

Find out more about Black Diamond including full access to the free equity report at:
www.RDInvesting.com/BDE

ENSCO PLC (NYSE: ESV) shares declined 1.96 percent to close at $54.47 a share Tuesday. The stock traded between $53.91 and $56.22 on volume of 3.95 million shares traded. Analysts at Barclays have recently downgraded the company?s rating to "equal weight" from "overweight".

Find out more about ENSCO including full access to the free equity report at:
www.RDInvesting.com/ESV

Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) closed at $5.92 a share Tuesday. The stock traded between $5.40 and $5.95 on volume of 230,907 shares traded. Analysts at Maxim Group have recently downgraded the company?s rating to "hold" from ?buy?. Shares of Sucampo Pharmaceuticals have gained approximately 20.0 percent year-to-date.

Find out more about Sucampo Pharmaceuticals including full access to the free equity report at:
www.RDInvesting.com/SCMP

Williams-Sonoma, Inc. (NYSE: WSM) shares declined 0.83 percent to close at $55.94 a share Tuesday. The stock traded between $55.34 and $56.85 on volume of 1.65 million shares traded. Analysts at Canaccord Genuity have recently downgraded the company?s rating to "hold" from "buy". Shares of Williams-Sonoma have gained approximately 28.0 percent year-to-date.

Find out more about Williams-Sonoma including full access to the free equity report at:
www.RDInvesting.com/WSM

Disclaimer: Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor's reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. Research Driven Investing has no financial relationship with any company whose stock is mentioned in this release.

Contact:
Research Driven Investing
info@rdinvesting.com